These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 1347936

  • 1. Pharmacologic treatment of attention deficit hyperactivity disorder.
    Greenhill LL.
    Psychiatr Clin North Am; 1992 Mar; 15(1):1-27. PubMed ID: 1347936
    [Abstract] [Full Text] [Related]

  • 2. Clonidine for treatment of attention-deficit/hyperactivity disorder.
    Med Lett Drugs Ther; 1996 Dec 06; 38(989):109-10. PubMed ID: 8957471
    [No Abstract] [Full Text] [Related]

  • 3. Attention deficit hyperactivity disorder in children.
    Ramchandani P, Joughin C, Zwi M.
    Clin Evid; 2002 Jun 06; (7):262-71. PubMed ID: 12230649
    [No Abstract] [Full Text] [Related]

  • 4. Attention deficit hyperactivity disorder in children.
    Ramchandani P, Joughin C, Zwi M.
    Clin Evid; 2002 Dec 06; (8):280-90. PubMed ID: 12603883
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Dexmethylphenidate for attention deficit hyperactivity disorder.
    Coury D.
    Expert Opin Pharmacother; 2009 Nov 06; 10(16):2679-85. PubMed ID: 19874250
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The stimulants.
    Wilens TE, Biederman J.
    Psychiatr Clin North Am; 1992 Mar 06; 15(1):191-222. PubMed ID: 1347939
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
    Pae CU.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun 30; 31(5):1149-50; author reply 1151-2. PubMed ID: 17493730
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Methylphenidate (Ritalin) treatment in attention deficit hyperactivity disorder].
    Shalev R, Gross-Tsur V.
    Harefuah; 1997 May 01; 132(9):672-5. PubMed ID: 9225587
    [No Abstract] [Full Text] [Related]

  • 15. [Use of methylphenidate in adults with attention deficit disorder with hyperactivity].
    Gauillard J, Castelnau C, Vacheron-Trystram MN, Cheref S, Caroli F.
    Encephale; 1997 May 01; 23(4):251-6. PubMed ID: 9417389
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
    Cox DJ, Merkel RL, Moore M, Thorndike F, Muller C, Kovatchev B.
    Pediatrics; 2006 Sep 01; 118(3):e704-10. PubMed ID: 16950962
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.